期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Graves病患者机体免疫状态分析 被引量：1

暂未订购
导出
摘要 目的:检测Graves病患者临床免疫指标,并对其机体免疫状态进行分析。方法:取Graves病患者(GD组)及正常对照者(NC组)成人外周静脉血,检测游离三碘甲状腺原氨酸、游离甲状腺激素、促甲状腺激素、白细胞分类计数、免疫球蛋白、补体等指标并进行比较。结果:GD组中性粒细胞百分比低于NC组,差异具有统计学意义(P<0.01),而淋巴细胞百分比、中间细胞百分比均高于NC组,差异具有统计学意义(均P<0.01);GD组血清IgA水平高于NC组,其血清C3、C4水平则低于NC组,差异均具有统计学意义(均P<0.05)。结论:Graves病患者机体细胞免疫及体液免疫均存在异常,可能与其发病机制有关。
作者 韩钧凌 黄伟平 王建真 彭锦
机构地区 中国人民解放军第 中国人民解放军第
出处 《实用医学杂志》 CAS 2008年第5期754-755,共2页 The Journal of Practical Medicine
关键词 格雷夫斯病 外周血白细胞 免疫球蛋白 补体
分类号 R581.1 [医药卫生—内分泌] R446.6 [医药卫生—诊断学]
  • 相关文献

参考文献11

  • 1Phenekos C, Vryonidou A, Gritzapis A D, et al. Th1 and Th2 serum eytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2) [J]. Neuroimmunomodulation, 2004, 11(4):209-213.
  • 2陈灏珠，戴自英，林果为，等．实用内科学[M]．12版.北京：人民卫生出版社，2005．1333—1336．
  • 3Akamizu T, Ozaki S, Hiratani H, et al. Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity [J]. Clin Exp Immunol, 2002, 127 ( 1 ) : 92-98.
  • 4赵宏,王玉华,朱奋勇,马志俊.自身免疫性甲状腺疾病患者血清Th1/Th2水平及临床意义[J].实用医学杂志,2005,21(1):45-46. 被引量：17
  • 5黄晖,刘鹏鹰.Graves病患者淋巴细胞亚群与血清IL-10、IL-18变化的相关性研究[J].实用医学杂志,2007,23(9):1336-1338. 被引量：5
  • 6陈光明,沈飞霞.Graves眼病与CTLA-4基因第1外显子A49G多态性及临床特点的相关性研究[J].实用医学杂志,2007,23(5):642-644. 被引量：8
  • 7Hidaka Y, Kimura M, Izumi Y, et al. Increased serum concentration of eosinophil-derived neurotoxin in patients with Graves' disease [J]. Thyroid, 2003, 13(2):129-132.
  • 8Metcalfe R, Jordan N, Watson P, et al. Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry [J]. J Clin Endocrinol Metab, 2002, 87(4) : 1754-1761.
  • 9Antonelli A, Palla R, Casarosa L, et al. IgG, IgA and C3 deposits in the extra-thyroidal manifestations of autoimmune Graves' disease: their in vitro solubilization by intravenous immunoglobulin [J]. Clin Exp Rheumatol, 1996, 14( Suppl 15):S31-S35.
  • 10Arason G J, Kolka R, Hreidarsson A B, et al. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A * Q0 [J]. Clin Exp Inamunol, 2005, 140(3) :572-579.

二级参考文献17

  • 1Drugarin D, Negru S, Koreck A, et al. The pattern of a T(H) 1 cytokine in autoimmune thyroiditis. Immunol Lett, 2000, 71 (2): 73 - 77.
  • 2Roura-Mir C, Catalfamo M, Sospedra M, et al. Single-cell analysis of intrathyroidal lymphcytes shows differential cytokine expression in Hashmoto's and Graves" disease. Eur J lmmunol, 1997, 27(12):3290 - 3302.
  • 3hoh M, Uchimura K, Makino M, et al. Production of IL-10 and 1L-12 in CD40 and interleukin 4-actirated monouclear cells from patients with Graves' disease. Cytokine, 2000, 12(6): 688 - 693.
  • 4Okumura M, Hidaka Y, Matsuzuka F, et al. CD30 expression and interleukin-4 and interferon gamma production of intrathyroidail ymphocytes in Graves" disease. Thyroid, 1999, 9(4): 333 -339.
  • 5Butch H B, WartofskY L. Graves'ophthalmopathy: current concepts regarding pathogenesis and management [J]. Endocr Rev, 1993,14(6) : 747-793.
  • 6Bartalena L, Marcocci C, Pinchera A. Graves' ophthalmopathy: a preventable disease [J]? Eur J Endocrinol, 2002, 146(4): 457-461.
  • 7Vaidya B, Imrie H, Perros P, et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy [J]. Lancet, 1999, 354(9180) : 743-744.
  • 8Bednarczuk T, Hiromatsu Y, Fukutani T, et al. Association of cytotoxic T-lymphocyte-associated antigen-4(CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations [J]. Eur J Endocrinol, 2003,148(17: 13-18.
  • 9Kouki T, Sawai Y, Gardine C A, et al. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the patho-genesis of Graves'disease [J]. J Immunol,2000, 165(11), 6606-6611.
  • 10高慧．甲状腺眼病[M]∥刘新民，潘长玉，张达青，等．实用内分泌学．北京：人民军医出版社，2004：218—227.

共引文献510

同被引文献10

  • 1Gessl A, Lemmens G R, Kautzky W A. Thyroid disorders. Handb Exp Pharmacol,2012, (214) :361-386.
  • 2Sugino K, Ito K, Nagahama M, et al. Changes in the thyroid function of Graves ' disease patients treated by subtotal thyroidectomy. Endocr J, 2012 : 745-763.
  • 3Sztal M S, Nakatani V Y, Bortolini L G, et al. Evidence for higher success rates and successful treatment earlier in graves' disease with higher radioactive iodine doses. Thyroid,2012 ,22 (10) :991-995.
  • 4Nwatsock J F, Taieb D, Tessonnier L, et al. Radioiodiue thyroid ablation in graves' hyperthyroidism: merits and pitfalls. World J Nucl Med,2012, 11(1) :7-11.
  • 5Lazarus J H, Bartalena L, Marcocci C, et, al. Glucocoiticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association. J Endocrinol Invest,2010, 33 (6) :409-413.
  • 6Bahn R S, Burch H B, Cooper D S, et al. Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract,2011, 17 (3) :456-520.
  • 7马中书,邱明才.糖皮质激素在自身免疫性甲状腺疾病治疗中的选择和应用[J].中国全科医学,2010,13(2):113-115. 被引量：46
  • 8罗顺葵,谢丹红.Graves病研究新进展[J].新医学,2010,41(3):202-205. 被引量：12
  • 9孟召伟,谭建.解读美国甲状腺协会和临床内分泌医师协会2011年甲亢诊治指南[J].国际放射医学核医学杂志,2011,35(4):193-201. 被引量：7
  • 10金进.泼尼松联合甲巯咪唑与单纯口服甲巯咪唑治疗Graves病疗效比较[J].蚌埠医学院学报,2012,37(6):699-701. 被引量：10

引证文献1

实用医学杂志
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部